Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension.
View / Open Files
Authors
Groves, Emily
Zalewska, Kasia I
Swietlik, Emilia M
Treacy, Carmen M
Martin, Jennifer M
Polwarth, Gary
Li, Wei
Guo, Jingxu
Baxendale, Helen E
Coleman, Stephen
Savinykh, Natalia
Coghlan, J Gerry
Corris, Paul A
Howard, Luke S
Johnson, Martin K
Church, Colin
Kiely, David G
Lawrie, Allan
Lordan, James L
Mackenzie Ross, Robert V
Pepke Zaba, Joanna
Wort, S John
Fiorillo, Edoardo
Orrù, Valeria
Cucca, Francesco
Rhodes, Christopher J
Gräf, Stefan
Morrell, Nicholas W
McKinney, Eoin F
UK National Cohort Study of Idiopathic and Heritable PAH Consortium
Publication Date
2022-07-01Journal Title
Am J Respir Crit Care Med
ISSN
1073-449X
Publisher
American Thoracic Society
Type
Article
This Version
VoR
Physical Medium
Print-Electronic
Metadata
Show full item recordCitation
Jones, R. J., De Bie, E. M., Groves, E., Zalewska, K. I., Swietlik, E. M., Treacy, C. M., Martin, J. M., et al. (2022). Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension.. Am J Respir Crit Care Med https://doi.org/10.1164/rccm.202108-1919OC
Abstract
Rationale: Autoimmunity is believed to play a role in idiopathic pulmonary arterial hypertension (IPAH). It is not clear whether this is causative or a bystander of disease and if it carries any prognostic or treatment significance. Objectives: To study autoimmunity in IPAH using a large cross-sectional cohort. Methods: Assessment of the circulating immune cell phenotype was undertaken using flow cytometry, and the profile of serum immunoglobulins was generated using a standardized multiplex array of 19 clinically validated autoantibodies in 473 cases and 946 control subjects. Additional glutathione S-transferase fusion array and ELISA data were used to identify a serum autoantibody to BMPR2 (bone morphogenetic protein receptor type 2). Clustering analyses and clinical correlations were used to determine associations between immunogenicity and clinical outcomes. Measurements and Main Results: Flow cytometric immune profiling demonstrates that IPAH is associated with an altered humoral immune response in addition to raised IgG3. Multiplexed autoantibodies were significantly raised in IPAH, and clustering demonstrated three distinct clusters: "high autoantibody," "low autoantibody," and a small "intermediate" cluster exhibiting high concentrations of ribonucleic protein complex. The high-autoantibody cluster had worse hemodynamics but improved survival. A small subset of patients demonstrated immunoglobulin reactivity to BMPR2. Conclusions: This study establishes aberrant immune regulation and presence of autoantibodies as key features in the profile of a significant proportion of patients with IPAH and is associated with clinical outcomes.
Keywords
Autoimmune, BMPR2, IPAH, autoantibodies, pulmonary arterial hypertension
Sponsorship
Medical Research Council (MC_UU_00002/4)
Wellcome Trust (220788/Z/20/Z)
Wellcome Trust (107881/Z/15/Z)
Medical Research Council (MR/K020919/1)
British Heart Foundation (None)
Identifiers
External DOI: https://doi.org/10.1164/rccm.202108-1919OC
This record's URL: https://www.repository.cam.ac.uk/handle/1810/335639
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk